Mia's Feed
Medical News & Research

AI-Assisted Chest X-ray Enhances Diagnosing Achalasia

AI-Assisted Chest X-ray Enhances Diagnosing Achalasia

Share this article

A new AI-powered approach utilizing plain chest X-rays offers a non-invasive, accurate method for early diagnosis of achalasia, potentially transforming screening and treatment outcomes.

2 min read

Achalasia is a disorder characterized by impaired movement of the esophagus, leading to symptoms such as difficulty swallowing, food regurgitation, and chest pain. Traditionally, diagnosing this condition involves invasive procedures like upper gastrointestinal endoscopy and high-resolution manometry, which can be uncomfortable for patients.

Recent advancements have introduced the use of plain chest X-ray imaging to identify signs associated with achalasia, such as esophageal dilation, twisting, and fluid retention. However, these radiographic signs are often vague and challenging to interpret accurately.

A groundbreaking development from Osaka Metropolitan University involves an innovative AI model designed to detect achalasia using only standard chest X-rays. Led by Dr. Tadashi Ochiai, Dr. Akinari Sawada, and Associate Professor Daiju Ueda, the research team trained their AI with 207 chest X-rays from 144 patients diagnosed with achalasia and 240 from similar-aged non-achalasia individuals. The model's effectiveness was tested on a separate dataset comprising 17 achalasia and 64 non-achalasia X-rays.

Results demonstrated remarkable accuracy, with the AI achieving an area under the curve (AUC) of 0.964, sensitivity of 94.1%, and specificity of 89.1%. Notably, the AI outperformed experienced physicians in accurately diagnosing the condition based on the same images.

The importance of early diagnosis cannot be overstated, as delays—averaging 6.5 years from symptom onset—can lead to worsening esophageal dilation and reduce treatment effectiveness. In Japan, where chest X-rays are frequently part of routine health checks, this AI tool could serve as a simple, minimally invasive screening method for early detection of achalasia, potentially improving patient outcomes.

The study, published in Clinical Gastroenterology and Hepatology, underscores the potential of AI to revolutionize the diagnostic process for esophageal disorders, facilitating quicker, more accurate, and less invasive diagnoses.

source: https://medicalxpress.com/news/2025-09-achalasia-diagnosis-ai-chest-ray.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Breakthrough in Vascularized Organoids Promises Advances in Research and Regenerative Medicine

A breakthrough in growing blood vessel-containing organoids could revolutionize disease modeling, drug testing, and regenerative therapies, enabling larger and more mature tissue development.

Mepolizumab Significantly Reduces Exacerbation Rates in COPD Patients with Eosinophilic Phenotype

Mepolizumab significantly decreases the rate of moderate and severe exacerbations in COPD patients with eosinophilic phenotype, offering a new targeted approach for managing this condition.

Impact of Early 20th Century Medical School Closures on Mortality Rates in the US

Discover how early 20th-century closures of US medical schools, driven by reforms like the Flexner Report, led to significant declines in mortality rates and improved public health outcomes.

The Risks of DIY Natural Skincare: Why Pantry Ingredients Can Harm Your Skin

Discover the dangers of using raw pantry ingredients like garlic, cayenne, and baking soda in DIY skincare. Learn why professional formulations are safer for your skin health.